Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2013 June;65(2) > Minerva Urologica e Nefrologica 2013 June;65(2):85-92

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

  EXPERTS IN STONE DISEASE


Minerva Urologica e Nefrologica 2013 June;65(2):85-92

language: English

Stents and stone disease

Van Der Merwe A. 1, Van Heerden H. 1, Bonkat G. 2, Heyns C. 1

1 Department Urology, Stellenbosch University Cape Town, South Africa;
2 Department Urology, Basel University Basel, Switzerland


PDF  


The use of stents in renal stone disease is relatively new. The main advantage is reduced pressure in the renal collecting system during times of infected obstructed collecting systems, surgery or obstructing stones. As much pain relieve theses stents offer when indicated, equally much morbidity is caused when stent materials interface with the human urothelium in terms of symptoms, perforations and the “forgotten stent”. This review aim to summarize some of the most important considerations when stents are used in stone disease.

top of page

Publication History

Cite this article as

Corresponding author e-mail

arvdm@sun.ac.za